Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-006836
Filing Date
2025-05-08
Accepted
2025-05-08 06:01:10
Documents
58
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sgmt-20250331x10q.htm   iXBRL 10-Q 1212851
2 EX-31.1 sgmt-20250331xex31d1.htm EX-31.1 13061
3 EX-31.2 sgmt-20250331xex31d2.htm EX-31.2 14029
4 EX-32.1 sgmt-20250331xex32d1.htm EX-32.1 9760
  Complete submission text file 0001558370-25-006836.txt   5654980

Data Files

Seq Description Document Type Size
5 EX-101.SCH sgmt-20250331.xsd EX-101.SCH 29161
6 EX-101.CAL sgmt-20250331_cal.xml EX-101.CAL 32904
7 EX-101.DEF sgmt-20250331_def.xml EX-101.DEF 164682
8 EX-101.LAB sgmt-20250331_lab.xml EX-101.LAB 328215
9 EX-101.PRE sgmt-20250331_pre.xml EX-101.PRE 249493
61 EXTRACTED XBRL INSTANCE DOCUMENT sgmt-20250331x10q_htm.xml XML 1049936
Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Filer) CIK: 0001400118 (see all company filings)

EIN.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41742 | Film No.: 25923618
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)